XT Series Cabinets, IV Compounding Technology and Analytics
Solutions Featured in Stand 49
MOUNTAIN VIEW, California,
March 22, 2017 /PRNewswire/
-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of
medication and supply management solutions to healthcare systems
and pharmacies, today announced it will showcase its XT Automated
Dispensing Cabinets, IV solutions and drug diversion analytics
software at the European Association of Hospital Pharmacists (EAHP)
Congress from March 22-24 in
Cannes, France. Together, these
solutions help support safer and more streamlined medication
distribution in hospitals.
Omnicell® XT Automated Dispensing Cabinets are
designed with new hardware features that improve workflow for
nurses—allowing them more time for patient-centered activities
while helping to increase safety and accuracy in medication
dispensing. The scalability of the XT system is responsive to a
growing health system, and the new technology is designed to easily
adapt to future innovations. Omnicell's automated dispensing
cabinets have been awarded the highest ranking from KLAS for 11
years in a row.
In addition to Omnicell's automated medication dispensing
cabinets, the following solutions will be displayed in Stand
49:
- i.v.STATION™, which prepares and dispenses
ready-to-administer, sterile compounded medications
- i.v.SOFT® Assist, an all-in-one IV workflow
solution for both hazardous and non-hazardous compounding
- Omnicell Analytics, a web-based diversion analytics tool
for detecting potential drug diversion within a health system
- Anywhere RN™, an application that allows
nurses to access automated dispensing cabinets from virtually any
hospital workstation
"We're excited to introduce Omnicell's comprehensive set of
solutions to the attendees at EAHP and demonstrate how our
innovations, including our new XT cabinets, are making a
significant impact in the way hospitals operate," said Arthur Van Dongen, general manager,
International at Omnicell. "The theme for this year's conference is
'Hospital pharmacists – catalysts for change,' and we feel that
pharmacists can achieve substantial and quantifiable change by
implementing this latest technology."
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create
safer and more efficient ways to manage medications and supplies
across all care settings. As a leader in medication and supply
dispensing automation, central pharmacy automation, IV robotics,
analytics software, and medication adherence and packaging systems,
Omnicell is focused on improving care across the entire healthcare
continuum—from the acute care hospital setting, to post-acute
skilled nursing and long-term care facilities, to the patient's
home.
Over 4,000 customers worldwide use Omnicell®
automation and analytics solutions to increase operational
efficiency, reduce medication errors, deliver actionable
intelligence and improve patient safety.
Omnicell's innovative medication adherence solutions, used by
over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve
patient adherence to prescriptions, helping to reduce costly
hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct
capabilities, particularly in central pharmacy, IV robotics, and
pharmacy software, creating the broadest medication management
product portfolio in the industry.
For more information about Omnicell, Inc. please
visit www.omnicell.com.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by PR Newswire and are
immediately thereafter posted on the company's external website,
omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks
of Omnicell, Inc.
- All other brand or product names may be trademarks or
registered trademarks of their respective companies.
Logo -
http://mma.prnewswire.com/media/326089/omnicell__inc__logo.jpg